Heavy Pharmaceutical Holdings: Announcement on the results of issuing the holding subsidiary's third instalment medium-term notes in 2024

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.